Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Nicoll

Showing results (21-30 of 28) with videos related to

Pageof 3
Sort By:
You have reached the last page of results.This site can display upto 28 results.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|September 22, 2000
Alterations in polyamine catabolic enzymes in human breast cancer tissueH M Wallace, J Duthie, D M Evans, et al.
The Journal of Urology|October 20, 2009
Laparoscopic management of ureteral endometriosis: the Stanford University hospital experience with 96 consecutive casesDorian Bosev, Linda M Nicoll, Lisa Bhagan, et al.
Journal of Minimally Invasive Gynecology|October 20, 2009
Endometriosis of the diaphragm: four cases treated with a combination of laparoscopy and thoracoscopyCamran Nezhat, Linda M Nicoll, Lisa Bhagan, et al.
Cancer Cell|December 9, 2008
Transient potent BCR-ABL inhibition is sufficient to commit chronic myeloid leukemia cells irreversibly to apoptosisNeil P Shah, Corynn Kasap, Christopher Weier, et al.
Cancer Cell|September 3, 2002
Multiple BCR-ABL kinase domain mutations confer polyclonal resistance to the tyrosine kinase inhibitor imatinib (STI571) in chronic phase and blast crisis chronic myeloid leukemiaNeil P Shah, John M Nicoll, Bhushan Nagar, et al.
Acta Paediatrica (Oslo, Norway : 1992)|June 17, 1998
Benign intracranial hypertension and recombinant growth hormone therapy in Australia and New ZealandP A Crock, J D McKenzie, A M Nicoll, et al.
Cytopathology : Official Journal of the British Society for Clinical Cytology|May 24, 2012
Prospective parallel randomized trial of the MultiCyte™ ThinPrep(®) imaging system: the Scottish experienceT J Palmer, S M Nicoll, M E McKean, et al.
The Journal of Clinical Investigation|August 22, 2007
Sequential ABL kinase inhibitor therapy selects for compound drug-resistant BCR-ABL mutations with altered oncogenic potencyNeil P Shah, Brian J Skaggs, Susan Branford, et al.
Pageof 3

Showing results (21-30 of 28) with videos related to

Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 28 results.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|September 22, 2000
Alterations in polyamine catabolic enzymes in human breast cancer tissueH M Wallace, J Duthie, D M Evans, et al.
The Journal of Urology|October 20, 2009
Laparoscopic management of ureteral endometriosis: the Stanford University hospital experience with 96 consecutive casesDorian Bosev, Linda M Nicoll, Lisa Bhagan, et al.
Journal of Minimally Invasive Gynecology|October 20, 2009
Endometriosis of the diaphragm: four cases treated with a combination of laparoscopy and thoracoscopyCamran Nezhat, Linda M Nicoll, Lisa Bhagan, et al.
Cancer Cell|December 9, 2008
Transient potent BCR-ABL inhibition is sufficient to commit chronic myeloid leukemia cells irreversibly to apoptosisNeil P Shah, Corynn Kasap, Christopher Weier, et al.
Cancer Cell|September 3, 2002
Multiple BCR-ABL kinase domain mutations confer polyclonal resistance to the tyrosine kinase inhibitor imatinib (STI571) in chronic phase and blast crisis chronic myeloid leukemiaNeil P Shah, John M Nicoll, Bhushan Nagar, et al.
Acta Paediatrica (Oslo, Norway : 1992)|June 17, 1998
Benign intracranial hypertension and recombinant growth hormone therapy in Australia and New ZealandP A Crock, J D McKenzie, A M Nicoll, et al.
Cytopathology : Official Journal of the British Society for Clinical Cytology|May 24, 2012
Prospective parallel randomized trial of the MultiCyte™ ThinPrep(®) imaging system: the Scottish experienceT J Palmer, S M Nicoll, M E McKean, et al.
The Journal of Clinical Investigation|August 22, 2007
Sequential ABL kinase inhibitor therapy selects for compound drug-resistant BCR-ABL mutations with altered oncogenic potencyNeil P Shah, Brian J Skaggs, Susan Branford, et al.
Pageof 3